Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...

Currently, there are no medical treatments for early or intermediate age-related macular degeneration (AMD ... New signs of choroidal neovascularization (CNV) activity include recurrence or ...

Dry age-related macular degeneration (AMD) management is currently based on regular follow-up for early detection of choroidal neovascularization (CNV), addressing the risk factors and prescribing ...

this treatment resulted in a remarkably efficacious CNV occlusion with minimal unfavorable phototoxicity. Gene therapy is a promising approach to treat age-related macular degeneration.

Fluorescein angiography enabled the identification of two major CNV patterns, known as 'classic' and 'occult' 55. Classic CNV is a discrete and well-demarcated area of hyperfluorescence ...

More information: Safe CNV removal is crucial for successful hESC-RPE transplantation in wet age-related macular degeneration ...

it also had anti-fibrotic effects after glaucoma filtration surgery and laser-induced choroidal neovascularization (CNV), a well-established method for assessing therapies for wet AMD and macular ...

YESAFILI is intended for the treatment of neovascular (wet AMD) age-related macular degeneration ... myopic choroidal neovascularisation (myopic CNV). It is highly similar to the reference ...

visual impairment due to diabetic macular oedema (DME) and visual impairment due to myopic choroidal neovascularisation (myopic CNV). It is a biosimilar to its reference product Eylea (aflibercept).